Antitoxin treatment for liver abscess caused by Clostridium perfringens

Toru Hifumi et al. Clin Mol Hepatol. 2013 Mar.

. 2013 Mar;19(1):97-8.

doi: 10.3350/cmh.2013.19.1.97.

No abstract available

Conflict of interest statement

The authors have no conflicts to disclose.

Author’s response to letter to the editor.
Koo YS, Kim YS. Koo YS, et al. Clin Mol Hepatol. 2013 Mar;19(1):98. Clin Mol Hepatol. 2013. PMID: 23720868 No abstract available.

Severe sepsis caused by a gas-forming Clostridium perfringens and Klebsiella variicola liver abscess following total pancreatectomy.
Dahl SS, Thorsteinsson M, Lambine TL, Penninga L. Dahl SS, et al. BMJ Case Rep. 2020 Oct 4;13(10):e238896. doi: 10.1136/bcr-2020-238896. BMJ Case Rep. 2020. PMID: 33012720 Free PMC article. No abstract available.

1. Kim JH, Jung ES, Jeong SH, Kim JS, Ku YS, Hahm KB, et al. A case of emphysematous hepatitis with spontaneous pneumoperitoneum in a patient with hilar cholangiocarcinoma. Korean J Hepatol. 2012;18:94–97. - PMC - PubMed
1. van Bunderen CC, Bomers MK, Wesdorp E, Peerbooms P, Veenstra J. Clostridium perfringens septicaemia with massive intravascular haemolysis: a case report and review of the literature. Neth J Med. 2010;68:343–346. - PubMed
1. Evans DG, Perkins FT. Fifth international standard for gas-gangrene antitoxin (perfringens) (clostridium welchii type a antitoxin) Bull World Health Organ. 1963;29:729–735. - PMC - PubMed
1. Lober B. Gas gangrene and other clostridium associated diseases. In: Mandell GL, Bennett JE, Dolin R, editors. Principle and Practice of Infectious Diseases. 5th ed. Churchill Livingstone Inc.; 2000. pp. 2549–2561.
1. Hifumi T, Takahashi M, Morokuma K, Haraguchi Y, Kato H, Koido Y, et al. Do you know the Clostridium perfringens antitoxin? J Jpn Soc intensive Care Med. 2010;17:287–289.